摘要
背景:炎症性肠病 (IBD) 的发病率在全球范围内持续上升。尽管药物治疗取得了进展,但克罗恩病 (CD) 和溃疡性结肠炎 (UC) 的发病机制仍未得到充分解释。迁移波是分析 IBD 流行的演变并推断其触发因素的具有挑战性的环境。 目的:我们的研究旨在概述有关第一代和第二代移民中 IBD 患病率和表型的文献。此外,我们旨在总结迁移历史并绘制与 IBD 分布的可能相关性。 方法:在对相关主题进行电子(PubMed 和 Web of Science)和手动搜索之后进行非系统性审查。 结果:总体而言,第一代移民倾向于保持本国的 IBD 风险。在下一代,风险往往会趋向于目的地国家的风险。较早的迁移年龄会调节 IBD 风险,这表明暴露于环境和社会经济因素的程度可能对疾病进展起决定性作用。一般来说,CD 需要更多时间才能达到与东道国相似的疾病负担,表明 UC 可能更多地受非遗传因素和遗传-非遗传相互作用的影响。 结论:IBD 表型和自然病程因移民和种族而异;然而,这些趋势在队列中并非一致。需要进一步研究分析遗传背景和环境风险因素对不同种族的影响,为识别高危个体、预防和早期诊断 IBD 提供证据。
关键词: 流行病学、克罗恩病、炎症性肠病、迁移、溃疡性结肠炎、危险因素。
Current Drug Targets
Title:Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back?
Volume: 22 Issue: 15
关键词: 流行病学、克罗恩病、炎症性肠病、迁移、溃疡性结肠炎、危险因素。
摘要:
Background: The incidence of inflammatory bowel disease (IBD) continues to rise worldwide. Despite the advances in pharmacotherapy, the etiopathogenesis of Crohn’s disease (CD) and ulcerative colitis (UC) remains underexplained. The migratory waves are a challenging setting to analyze the evolution of IBD prevalence and to infer its triggering factors.
Objective: Our study aimed to overview the literature regarding IBD prevalence and phenotype in first- and second-generation migrants Also, we aimed to summarize the migration history and to draw a possible correlation with IBD distribution.
Methods: A non-systematic review was performed following electronic (PubMed and Web of Science) and manual searches on relevant topics.
Results: Overall, first-generation migrants tend to maintain the IBD risk of the native country. On the following generation, the risk tends to converge to that of the destination country. Earlier age at migration modulates IBD risk, suggesting that the degree of exposure to environmental and socio-economic factors can be decisive for disease progression. In general, CD needs more time to reach a disease burden similar to that of the host country, indicating that UC may be more affected by nongenetic factors and genetic-nongenetic interactions.
Conclusion: IBD phenotypes and natural history vary in migrants and according to ethnicity; however, the trends are not consensual among cohorts. Further studies are warranted to analyze the effect of genetic background and environmental risk factors in different ethnic groups, providing evidence to move towards the identification of at-risk individuals, prevention, and earlier diagnosis of IBD.
Export Options
About this article
Cite this article as:
Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back?, Current Drug Targets 2021; 22 (15) . https://dx.doi.org/10.2174/1389450122666210203193817
DOI https://dx.doi.org/10.2174/1389450122666210203193817 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD
Current Medicinal Chemistry High Performance Capillary Electrophoresis Characteristic Fingerprint of Schisandra chinensis
Current Pharmaceutical Analysis AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans
Current Pharmaceutical Design Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors
Current Pharmaceutical Design Editorial:
Drug Metabolism Letters The Association Between Obstructive Sleep Apnea and Allergic Rhinitis: Current Literature Review
Current Respiratory Medicine Reviews Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry The Neuropathology of Vascular Disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
Current Alzheimer Research 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs)
Current Medicinal Chemistry Melatonin Could Be Beneficial in SARS-CoV-2 Therapy
The Natural Products Journal Role of Galectins in Allergic Disorders
Recent Patents on Inflammation & Allergy Drug Discovery RNA-Mediated Therapeutics: From Gene Inactivation to Clinical Application
Current Topics in Medicinal Chemistry A Concise Review on the Role of Natural and Synthetically Derived Peptides in Colorectal Cancer
Current Topics in Medicinal Chemistry Adenoid Hypertrophy, Craniofacial Growth and Obstructive Sleep Apnea: A Crucial Triad in Children
Current Respiratory Medicine Reviews From the Old Immunitas to the Modern Immunity: Do We Need a New Name for the Immune System?
Current Immunology Reviews (Discontinued) An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Developmental Current and Future Therapy for Severe Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor
Medicinal Chemistry Immunopathogenesis of Severe Asthma
Current Pharmaceutical Design